Erectile Dysfunction
Erectile Dysfunction is a condition concerning erectile function—the outcome addressed by the evidence summarized here. The sources supporting possible interventions are not uniform: they include a randomized controlled trial, a meta-analysis, and pharmacology references describing traditional use or a proposed mechanism.
A concise starting point for understanding Erectile Dysfunction.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
None of these options has good evidence yet. Best evidence first.
1 option:1 not enough evidence
Acceptance and Commitment Therapy (ACT)practiceNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
In a single-arm feasibility study of 8 people with Erectile Dysfunction, erectile function improved, while changes in intercourse satisfaction and overall satisfaction were trends; orgasmic function and sexual desire did not significantly change. The study authors noted that a larger RCT is needed.
Open the Acceptance and Commitment Therapy (ACT) page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition1 listedThe best we have, but the evidence is still weak
- →PracticesAcceptance and Commitment Therapy (ACT)CertaintyLowSourceClinical
In a single-arm feasibility study of 8 people with Erectile Dysfunction, erectile function improved (IIEF-15, P = 0.03), while changes in intercourse satisfaction and overall satisfaction were trends (P = 0.10); orgasmic function and sexual desire did not significantly change. The study authors noted that a larger RCT is needed.
Who was studied
- People with a condition
Open Acceptance and Commitment Therapy (ACT)Study result
Single-arm feasibility study; significant improvement in IIEF-15 erectile function (P = 0.03), trends in intercourse satisfaction and overall satisfaction (P = 0.10), no significant change in orgasmic function or sexual desire; larger RCT needed.
What to avoid
Interventions recorded as making it worseNothing in this library is currently recorded as making Erectile Dysfunction worse. Coverage is partial, and absence here is not evidence of safety.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Erectile Dysfunction is a condition concerning erectile function—the outcome addressed by the evidence summarized here. The sources supporting possible interventions are not uniform: they include a randomized controlled trial, a meta-analysis, and pharmacology references describing traditional use or a proposed mechanism. These sources should not be interpreted as providing equivalent evidence or as showing that the options are interchangeable treatments; a clinician can help place the information in context.
Evidence-backed options
The options associated with erectile dysfunction do not have a uniform level of support. Evidence spans a clinical study, a meta-analysis, pharmacology references describing traditional or contemporary use, and animal research. This mix means that findings based on human outcomes should be distinguished from plausible use or results observed in animals; the options should not be interpreted as equally established.
The clinical evidence described for Garlic involved its use alongside tadalafil rather than Garlic alone, in participants who had a poor response to tadalafil by itself. This limits what can be concluded about Garlic as a standalone option or about whether the finding applies to people with different treatment responses.
The available findings do not specify how long the options were taken, how quickly changes appeared, or whether benefits persisted after use. As a result, they cannot establish a typical time to effect or an appropriate duration. The evidence is also not sufficient to compare these options with one another or to determine which people are most likely to benefit. A clinician can help interpret these findings in the context of erectile dysfunction and any existing treatment.